{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:41:28Z","timestamp":1756809688377},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/adm.0b013e31819b7bff","type":"journal-article","created":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T07:12:36Z","timestamp":1251184356000},"page":"111-119","source":"Crossref","is-referenced-by-count":12,"title":["Pathologic Gambling: Biological and Clinical Considerations"],"prefix":"10.1097","volume":"3","author":[{"given":"Jocelyn L.","family":"Topf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah W.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210126","article-title":"Diagnostic and Statistical Manual of Mental Disorders. 4th ed.","year":"1994"},{"key":"R4-1-20210126","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4088\/JCP.v66n0504","article-title":"Co-morbidity of DSM-IV pathological gambling and other psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"66","author":"Petry","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R5-1-20210126","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1037\/0893-164X.21.4.431","article-title":"Gambling, health and age: Data from the National Epidemiologic Survey on Alcohol and Related Conditions.","volume":"21","author":"Desai","year":"2007","journal-title":"Psychol Addict Behav"},{"key":"R6-1-20210126","article-title":"Pathological Gambling: A Critical Review.","year":"1999"},{"key":"R7-1-20210126","article-title":"Diagnostic and Statistical Manual of Mental Disorders. 3rd ed.","year":"1980"},{"key":"R8-1-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/S1092852900006003","article-title":"Serotonergic and noradrenergic function in pathological gambling.","volume":"3","author":"DeCaria","year":"1998","journal-title":"CNS Spectr"},{"key":"R9-1-20210126","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1017\/S1092852900015145","article-title":"Serotonin dysfunction in pathological gamblers: Increased prolactin response to oral m-CPP versus placebo.","volume":"11","author":"Pallanti","year":"2006","journal-title":"CNS Spectr"},{"key":"R10-1-20210126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hup.470060503","article-title":"Serotonin and gambling dependence.","volume":"6","author":"Moreno","year":"1991","journal-title":"Hum Psychopharmacol"},{"key":"R11-1-20210126","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/alcalc\/37.6.522","article-title":"Neurochemical markers of alcoholism vulnerability in humans.","volume":"37","author":"Ratsma","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"R12-1-20210126","first-page":"1725","article-title":"Neuropsychopharmacology: The 5th Generation of Progress.","author":"Potenza","year":"2002"},{"key":"R13-1-20210126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1092852900006799","article-title":"Altered CSF 5-HIAA disposition in pathological male gamblers.","volume":"4","author":"Nordin","year":"1999","journal-title":"CNS Spectr"},{"key":"R14-1-20210126","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jpsychires.2005.06.003","article-title":"CSF monoamine patterns in pathological gamblers and healthy controls.","volume":"40","author":"Nordin","year":"2006","journal-title":"J Psychiatr Res"},{"key":"R15-1-20210126","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archpsyc.1996.01830030029006","article-title":"Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.","volume":"53","author":"Fils-Aime","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"R16-1-20210126","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.neunet.2006.03.004","article-title":"Neural systems implicated in delayed and probabilistic reinforcement.","volume":"19","author":"Cardinal","year":"2006","journal-title":"Neural Netw"},{"key":"R17-1-20210126","first-page":"397","article-title":"Genetic contribution to pathological gambling: Possible association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected men.","volume":"9","author":"Perez de Castro","year":"1999","journal-title":"Pharmacogen"},{"key":"R18-1-20210126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1021271029163","article-title":"Genetics of pathological gambling.","volume":"19","author":"Ibanez","year":"2003","journal-title":"J Gambl Stud"},{"key":"R19-1-20210126","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2114\/jpa.18.37","article-title":"Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate.","volume":"18","author":"Shinohara","year":"1999","journal-title":"Appl Human Sci"},{"key":"R20-1-20210126","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.psyneuen.2004.03.005","article-title":"Neuroendocrine response to casino gambling in problem gamblers.","volume":"29","author":"Meyer","year":"2004","journal-title":"Psychoneuroendocrinol"},{"key":"R21-1-20210126","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S0033291796003789","article-title":"Altered dopamine function in pathological gambling.","volume":"27","author":"Bergh","year":"1997","journal-title":"Psychol Med"},{"key":"R22-1-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.npp.1300333","article-title":"Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers.","volume":"29","author":"Zack","year":"2004","journal-title":"Neuropsyhcopharmacol"},{"key":"R23-1-20210126","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/sj.npp.1301295","article-title":"A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers.","volume":"32","author":"Zack","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"R24-1-20210126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pbb.2007.12.025","article-title":"A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers.","volume":"89","author":"Fong","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"R25-1-20210126","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v69n0314","article-title":"Olanzapine in the treatment of pathological gambling: A negative randomized placebo-controlled trial.","volume":"69","author":"McElroy","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R26-1-20210126","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0680","article-title":"Drug insight: Impulse control disorders and dopamine therapies in Parkinson\u2019s disease.","volume":"3","author":"Potenza","year":"2007","journal-title":"Nat Clin Practice Neurosci"},{"key":"R27-1-20210126","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease.","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"R29-1-20210126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S109285290000599X","article-title":"The molecular genetics of pathological gambling.","volume":"3","author":"Comings","year":"1998","journal-title":"CNS Spectr"},{"key":"R30-1-20210126","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction.","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat Neurosci"},{"key":"R31-1-20210126","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1530-0277.2007.00470.x","article-title":"Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1.","volume":"31","author":"Dick","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R32-1-20210126","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10899-007-9060-x","article-title":"Dopamine genes and pathological gambling in discordant sib-pairs.","volume":"23","author":"Sabbatini da Silva Lobo","year":"2007","journal-title":"J Gambl Stud"},{"key":"R33-1-20210126","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: A tale of norepinephrine and drug addiction.","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacol"},{"key":"R34-1-20210126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1988.01800280085011","article-title":"Pathological gambling. A psychobiological study.","volume":"45","author":"Roy","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R35-1-20210126","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archpsyc.1989.01810080009001","article-title":"Extraversion in pathological gamblers. Correlates with indexes of noradrenergic function.","volume":"46","author":"Roy","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"R36-1-20210126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1525-1497.2002.10812.x","article-title":"Gambling: An addictive behavior with health and primary care implications.","volume":"17","author":"Potenza","year":"2002","journal-title":"J Gen Int Med"},{"key":"R37-1-20210126","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: A pathology of motivation and choice.","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R38-1-20210126","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1001\/archpsyc.60.8.828","article-title":"Gambling urges in pathological gamblers: An fMRI study.","volume":"60","author":"Potenza","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R39-1-20210126","doi-asserted-by":"crossref","first-page":"s127","DOI":"10.1006\/nimg.1996.0063","article-title":"Functional MRI and the study of OCD: From symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala.","volume":"4","author":"Breiter","year":"1996","journal-title":"Neuroimage"},{"key":"R40-1-20210126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1023\/A:1021223113233","article-title":"Risky business: Emotion, decision-making, and addiction.","volume":"19","author":"Bechara","year":"2003","journal-title":"J Gambling Stud"},{"key":"R41-1-20210126","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","article-title":"The neurobiology and genetics of impulse control disorders: Relationships to drug addictions.","volume":"75","author":"Brewer","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R42-1-20210126","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1176\/appi.ajp.160.11.1990","article-title":"An fMRI stroop study of ventromedial prefrontal cortical function in pathological gamblers.","volume":"160","author":"Potenza","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R43-1-20210126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archpsyc.60.6.601","article-title":"A functional magnetic resonance imaging study of bipolar disorder: State- and trait-related dysfunction in ventral prefrontal cortices.","volume":"60","author":"Blumberg","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R44-1-20210126","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/hbm.20344","article-title":"Prefrontal cortex activity is reduced in gambling and nongambling substance users during decision-making.","volume":"28","author":"Tanabe","year":"2007","journal-title":"Hum Brain Mapp"},{"key":"R45-1-20210126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nn1378","article-title":"Pathological gambling is linked to reduced activation of the mesolimbic reward system.","volume":"8","author":"Reuter","year":"2005","journal-title":"Nat Neurosci"},{"key":"R46-1-20210126","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1053-8119(02)00057-5","article-title":"A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: Characterization with rapid event-related fMRI.","volume":"18","author":"Knutson","year":"2003","journal-title":"Neuroimage"},{"key":"R47-1-20210126","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1126\/science.1100907","article-title":"Separate neural systems value immediate and delayed monetary rewards.","volume":"306","author":"McClure","year":"2004","journal-title":"Science"},{"key":"R48-1-20210126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15622970510029768","article-title":"Imaging monetary reward in pathological gamblers.","volume":"6","author":"Hollander","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"R49-1-20210126","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuroimage.2006.11.043","article-title":"Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics.","volume":"35","author":"Wrase","year":"2007","journal-title":"Neuroimage"},{"key":"R51-1-20210126","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1523\/JNEUROSCI.4862-03.2004","article-title":"Incentive-elicited brain activation in adolescents: Similarities and differences from young adults.","volume":"24","author":"Bjork","year":"2004","journal-title":"J Neurosci"},{"key":"R52-1-20210126","first-page":"22A","article-title":"Motivation in children of alcoholics.","volume":"28","author":"Hommer","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R53-1-20210126","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1098\/rstb.2008.0100","article-title":"The neurobiology of pathological gambling and drug addiction: An overview and new findings.","volume":"363","author":"Potenza","year":"2008","journal-title":"Phil Trans Royal Soc B"},{"key":"R54-1-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathological gambling.","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R55-1-20210126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: A multi-center randomized controlled trial.","volume":"18","author":"Grant","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R56-1-20210126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling disorder.","volume":"63","author":"Kim","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R57-1-20210126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4088\/JCP.v66n0104","article-title":"Sertraline treatment of pathological gambling: A pilot study.","volume":"66","author":"Saiz-Ruiz","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R58-1-20210126","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","article-title":"Escitalopram treatment of pathological gambling with co-occurring anxiety: An Open-Label Pilot Study with Double-Blind Discontinuation.","volume":"21","author":"Grant","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R59-1-20210126","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2165\/00023210-200418150-00005","article-title":"Role of the serotonergic system in the neurobiology of alcoholism: Implications for treatment.","volume":"18","author":"Johnson","year":"2004","journal-title":"CNS Drugs"},{"key":"R60-1-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/JCP.v59n0403","article-title":"Opioid antagonists in the treatment of impulse-control disorders.","volume":"59","author":"Kim","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R61-1-20210126","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1176\/appi.ajp.162.8.1423","article-title":"Anticraving medications for relapse prevention: A possible new class of psychoactive medications.","volume":"162","author":"O\u2019Brien","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R62-1-20210126","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R63-1-20210126","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","article-title":"A double-blind, placebo-controlled study of the opioid antagonist naltrexone in the treatment of pathological gambling urges.","volume":"69","author":"Grant","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R64-1-20210126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.","volume":"163","author":"Grant","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R65-1-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00213-008-1235-3","article-title":"Predicting treatment response to opiate antagonists and placebo in the treatment of pathological gambling.","volume":"200","author":"Grant","year":"2008","journal-title":"Psychopharmacol"},{"key":"R66-1-20210126","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archpsyc.57.7.666","article-title":"Common genetic vulnerability for pathological gambling and alcohol dependence in men.","volume":"57","author":"Slutske","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R67-1-20210126","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacol"},{"key":"R68-1-20210126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","article-title":"Lithium and valproate treatment of pathological gambling: A randomized single-blind study.","volume":"63","author":"Pallanti","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R69-1-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R70-1-20210126","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of bupropion in the treatment of pathological gambling.","volume":"24","author":"Black","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R71-1-20210126","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.jcp.0000264985.25109.25","article-title":"Bupropion in the treatment of pathological gambling: A randomized, double-blind, placebo-controlled, flexible-dose study.","volume":"27","author":"Black","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R72-1-20210126","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.v66n1121d","article-title":"Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.","volume":"66","author":"Pittenger","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R73-1-20210126","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4088\/JCP.v68n0123f","article-title":"Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania.","volume":"68","author":"Coric","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R74-1-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.jcp.0000264976.86990.00","article-title":"N-acetyl cysteine in the treatment of grooming disorders.","volume":"27","author":"Odlaug","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R75-1-20210126","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","article-title":"N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study.","volume":"62","author":"Grant","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R76-1-20210126","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders.","volume":"165","author":"Dutra","year":"2008","journal-title":"Am J Psych"},{"key":"R77-1-20210126","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.142.4.366","article-title":"Controlled comparison of aversive therapy and imaginal desensitization in compulsive gambling.","volume":"142","author":"McConaghy","year":"1983","journal-title":"Br J Psychiatry"},{"key":"R78-1-20210126","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1192\/bjp.159.3.390","article-title":"Comparison of imaginal desensitisation with other behavioural treatments of pathological gambling. A two- to nine-year follow-up.","volume":"159","author":"McConaghy","year":"1991","journal-title":"Br J Psychiatry"},{"key":"R79-1-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1352465800016830","article-title":"Comparative effectiveness of three therapeutic modalities in psychological treatment of pathological gambling.","volume":"24","author":"Echeburua","year":"1996","journal-title":"Behav Cog Psychother"},{"key":"R80-1-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0005-7894(00)80019-2","article-title":"Relapse prevention in the treatment of slot-machine gambling: Long-term outcome.","volume":"31","author":"Echeburua","year":"2000","journal-title":"Behav Ther"},{"key":"R81-1-20210126","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1037\/0022-006X.65.5.727","article-title":"Cognitive and behavioral treatment of pathological gambling: A controlled study.","volume":"65","author":"Sylvain","year":"1997","journal-title":"J Consult Clin Psychol"},{"key":"R82-1-20210126","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/00005053-200111000-00007","article-title":"Cognitive treatment of pathological gambling.","volume":"189","author":"Ladouceur","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"R83-1-20210126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0005-7967(02)00036-0","article-title":"Group therapy for pathological gamblers: A cognitive approach.","volume":"41","author":"Ladouceur","year":"2003","journal-title":"Behav Res Ther"},{"key":"R84-1-20210126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1037\/0022-006X.69.1.50","article-title":"Motivational enhancement and self-help treatments for problem gambling.","volume":"69","author":"Hodgins","year":"2001","journal-title":"J Consult Clin Psychology"},{"key":"R85-1-20210126","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10899-004-1919-5","article-title":"Gamblers Anonymous and cognitive-behavioral therapies for pathological gamblers.","volume":"21","author":"Petry","year":"2005","journal-title":"J Gambling Stud"},{"key":"R86-1-20210126","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1192\/bjp.152.2.284","article-title":"An outcome study of Gamblers Anonymous.","volume":"152","author":"Stewart","year":"1988","journal-title":"Br J Psychiatry"},{"key":"R87-1-20210126","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0306-4603(02)00233-2","article-title":"Patterns and correlates of gamblers anonymous attendance in pathological gamblers seeking professional treatment.","volume":"28","author":"Petry","year":"2003","journal-title":"Addict Behav"},{"key":"R88-1-20210126","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1037\/0022-006X.74.3.555","article-title":"Cognitive-behavioral therapy for pathological gamblers.","volume":"74","author":"Petry","year":"2006","journal-title":"J Consult Clin Psychology"},{"key":"R89-1-20210126","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/appi.ajp.162.11.2184","article-title":"Impulse control disorders in adult psychiatric inpatients.","volume":"162","author":"Grant","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R90-1-20210126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.genhosppsych.2005.09.004","article-title":"Severity of gambling is associated with physical and emotional health in urban primary care patient.","volume":"28","author":"Morasco","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"key":"R91-1-20210126","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1037\/0893-164X.16.1.76","article-title":"Disordered gambling among university-based medical and dental patients: A focus on internet gambling.","volume":"16","author":"Ladd","year":"2002","journal-title":"Psychol Addict Behav"},{"key":"R92-1-20210126","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/archfami.8.6.515","article-title":"Prevalence of gambling disorders in a primary care setting.","volume":"8","author":"Pasternak","year":"1999","journal-title":"Arch Fam Med"},{"key":"R93-1-20210126","first-page":"e1","article-title":"Problem and pathological gambling in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry.","volume":"2009","author":"Desai","year":"16","journal-title":"ePub June"}],"container-title":["Journal of Addiction Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01271255-200909000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:33:27Z","timestamp":1618032807000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01271255-200909000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/adm.0b013e31819b7bff","relation":{},"ISSN":["1932-0620"],"issn-type":[{"value":"1932-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}